{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:59:52Z","timestamp":1778875192830,"version":"3.51.4"},"reference-count":27,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1995,7]]},"abstract":"<jats:p>AIMS--To analyse the distribution of OV-TL 3 and MOv18 in normal ovarian tissue to determine which antibody is most suitable for (radio)immunotherapy of ovarian carcinoma. METHODS--The distribution of OV-TL 3 and MOv18 was determined using immunohistochemistry and flow cytometry. RESULTS--Epithelial and other cells in many tissues, and leucocytes in peripheral blood, bone marrow and spleen stained positively with OV-TL 3. The staining pattern of MOv18 in normal tissues was more restricted and was confined to epithelial cells in the lung, kidney, pancreas, salivary gland, ovary, Fallopian tubes, and cervix. Reactivity was also observed with pneumocytes in the lung, tubuli in the kidney, acinar cells in the salivary gland and pancreas, in the placenta, and with Kupffer cells in the liver. The staining pattern of chimeric MOv18 was identical with the murine form. OV-TL 3 and MOv18 reacted with 100% and 98% (45\/46) of the 46 tested epithelial ovarian cancers, respectively. In ovarian carcinoma tissue homogeneous staining of epithelial cells was observed with OV-TL 3 and more heterogeneous staining with MOv18. In 12 and nine patients, respectively, a difference in staining intensity for OV-TL 3 and MOv18 was observed between various tumour samples from the same patient. CONCLUSION--MOv18 has greater therapeutic potential because of its restricted reactivity with normal tissues and especially, in contrast to OV-TL 3, its lack of reactivity with haematopoietic cells.<\/jats:p>","DOI":"10.1136\/jcp.48.7.631","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"631-636","source":"Crossref","is-referenced-by-count":31,"title":["Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue."],"prefix":"10.1136","volume":"48","author":[{"given":"M R","family":"Buist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C F","family":"Molthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Kenemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1995,7,1]]},"reference":[{"key":"ref_1","first-page":"781","article-title":"Monoclonal antibody against human ovarian tumor-associated antigens","volume":"76","author":"Poels, L.G.; Peters, D.; van Megen, Y.; Vooijs, P.G.; Veheijen, R.H.M.; Willemen, A.","year":"1986","unstructured":"Poels LG, Peters D, van Megen Y, Vooijs PG, Veheijen RHM, Willemen A, et al. Monoclonal antibody against human ovarian tumor-associated antigens. Nad Cancer Inst 1986;76:781-7.","journal-title":"Nad Cancer Inst"},{"key":"ref_2","first-page":"1802","article-title":"Characterization of human ovarian carcinoma associated antigens defined by novel monoclonal antibodies with tumor restricted specificity","volume":"39","author":"Miotti, S.; Canevari, S.; Menard, D.; Mezzanzanica, D.; Porro, G.; Pupa, S.M.","year":"1987","unstructured":"Miotti S, Canevari S, Menard D, Mezzanzanica D, Porro G, Pupa SM, et al. Characterization of human ovarian carcinoma associated antigens defined by novel monoclonal antibodies with tumor restricted specificity. Int Jf Cancer 1987;39:1802-10.","journal-title":"Int Jf Cancer"},{"key":"ref_3","first-page":"1802","article-title":"Immunoscintigraphy of ovarian cancer with indium-l l labeled OV-TL 3 (Fab')2 monoclonal antibody","volume":"31","author":"Massuger, L.F.A.G.; Kenemans, P.; Claessens, R.A.M.J.; Verheijen, R.H.M.; Schijf, C.P.T.; Strijk, S.P.","year":"1990","unstructured":"Massuger LFAG, Kenemans P, Claessens RAMJ, Verheijen RHM, Schijf CPT, Strijk SP, et al. Immunoscintigraphy of ovarian cancer with indium-l l labeled OV-TL 3 (Fab')2 monoclonal antibody. Nucd Med 1990;31: 1802-10.","journal-title":"Nucd Med"},{"key":"ref_4","first-page":"724","article-title":"Radioimmunoscintigraphy of ovarian cancerwith","volume-title":"the MOv1 8 monoclonal antibody. EurJ'Cancer","volume":"27","author":"Crippa, F.; Buraggi, G.L.; Di Re, E.; Gasparini, M.; Seregni, E.; Canevari, S.","year":"1991","unstructured":"Crippa F, Buraggi GL, Di Re E, Gasparini M, Seregni E, Canevari S, et al. Radioimmunoscintigraphy of ovarian cancerwith the MOv1 8 monoclonal antibody. EurJ'Cancer 1991;27:724-9."},{"key":"ref_5","first-page":"7","article-title":"Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes. A multicentre study","volume":"48","author":"Bolhuis, R.L.H.; Lamers, C.H.J.; Goey, S.H.; Eggermont, A.M.M.; Trimbos, J.B.; Stoter, G.","year":"1992","unstructured":"Bolhuis RLH, Lamers CHJ, Goey SH, Eggermont AMM, Trimbos JB, Stoter G, et al. Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes. A multicentre study. IntJ Cancer 1992;48(Suppl 7):78-81.","journal-title":"IntJ Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1525-1438.1992.02010023.x","article-title":"Radioimmunotargeting on ovarian carcinoma patients with indium-l l labeled monoclonal antibody OV-TL 3 F(ab) 2: pharmacokinetics, tissue distribution, and tumor imaging","volume":"2","author":"Buist, M.R.; Kenemans, P.; Vermorken, J.B.; Golding, R.P.; Burger, C.W.; den Hollander, W.","year":"1992","unstructured":"Buist MR, Kenemans P, Vermorken JB, Golding RP, Burger CW, den Hollander W, et al. Radioimmunotargeting on ovarian carcinoma patients with indium-l l labeled monoclonal antibody OV-TL 3 F(ab)2: pharmacokinetics, tissue distribution, and tumor imaging. Int Gynecol Cancer 1992;2:23-34.","journal-title":"Int Gynecol Cancer"},{"key":"ref_7","first-page":"2000","article-title":"Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen","volume":"33","author":"MolthoffCFM, Buist M.R.; P, Kenemans; HM, Pinedo; E, Boven","year":"1992","unstructured":"MolthoffCFM, Buist MR, Kenemans P, Pinedo HM, Boven E. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen. Nucl Med 1992; 33:2000-5.","journal-title":"Nucl Med"},{"key":"ref_8","first-page":"2448","article-title":"Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing","volume":"54","author":"Coney, L.R.; Mezzanzanica, D.; Sanborn, D.; Casalini, P.; Colnaghi, M.I.; Zurawski, V.R.","year":"1994","unstructured":"Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res 1994;54:2448-55.","journal-title":"Cancer Res"},{"key":"ref_9","first-page":"5413","article-title":"Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 and (Fab')2 fragments in ovarian carcinoma patients","volume":"53","author":"Buist, M.R.; Kenemans, P.; den Hollander, W.; Vermorken, J.B.; Molthoff, C.F.M.; Burger, C.W.","year":"1993","unstructured":"Buist MR, Kenemans P, den Hollander W, Vermorken JB, Molthoff CFM, Burger CW, et al. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 and (Fab')2 fragments in ovarian carcinoma patients. Cancer Res 1993;53:5413-18.","journal-title":"Cancer Res"},{"key":"ref_10","first-page":"5416","article-title":"An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains","volume":"52","author":"Campbell, I.G.; Freemont, P.S.; Foulkes, W.; Trowsdale, J.","year":"1992","unstructured":"Campbell IG, Freemont PS, Foulkes W, Trowsdale J. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res 1992;52:5416-20.","journal-title":"Cancer Res"},{"key":"ref_11","first-page":"5329","article-title":"Folatebinding protein in a marker for ovarian cancer","volume":"51","author":"Campbell, I.G.; Jones, T.A.; Foulkes, W.D.; Trowsdale, J.","year":"1991","unstructured":"Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folatebinding protein in a marker for ovarian cancer. Cancer Res 1991;51:5329-38.","journal-title":"Cancer Res"},{"key":"ref_12","first-page":"6125","article-title":"Cloning of a tumorassociated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein","volume":"51","author":"Coney, L.R.; Tomassetti, A.; Carayannopoulos, L.; Frasca, V.; Kamen, B.A.; Colnaghi, M.I.","year":"1991","unstructured":"Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI, et al. Cloning of a tumorassociated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 1991;51: 6125-35.","journal-title":"Cancer Res"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ijc.2910470202","article-title":"Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest","volume":"47","author":"Stein, R.; Goldenberg, D.M.; Mattes, M.J.","year":"1991","unstructured":"Stein R, Goldenberg DM, Mattes MJ. Normal tissue reactivity of four anti-tumor monoclonal antibodies of clinical interest. Int J Cancer 1991;47:163-9.","journal-title":"Int J Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jcp.41.6.644","article-title":"Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinoma","volume":"41","author":"Henzen-Logmans, S.C.; Schipper, N.W.; Poels, L.G.; Kenemans, P.; Meyer, C.J.L.M.","year":"1988","unstructured":"Henzen-Logmans SC, Schipper NW, Poels LG, Kenemans P, Meyer CJLM. Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinoma. J Clin Pathol 1988;41:644-9.","journal-title":"J Clin Pathol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9378(90)91288-N","article-title":"Heterogeneity of antigen expression in advanced epithelial ovarian cancer","volume":"162","author":"Berchuck, A.; Olt, G.J.; Soisson, A.P.; Kanel, A.; Soper, J.T.; Boyer, C.M.; etal","year":"1990","unstructured":"Berchuck A, Olt GJ, Soisson AP, Kanel A, Soper JT, Boyer CM, etal. Heterogeneity of antigen expression in advanced epithelial ovarian cancer. Am J Obstet Gynecol 1990;162: 883-8.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_16","first-page":"15","article-title":"Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens","volume":"10","author":"Boerman, O.C.; van Niekerk, C.C.; Makkink, W.K.; Hanselaar, A.G.J.M.; Kenemans, P.","year":"1991","unstructured":"Boerman OC, van Niekerk CC, Makkink WK, Hanselaar AGJM, Kenemans P. Comparative immunohistochemical study of four monoclonal antibodies directed against ovarian carcinoma-associated antigens. IntJ GynecolPathol 1991;10: 15-25.","journal-title":"IntJ GynecolPathol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast, R.C.; Klug, T.L.; John, E.; Jenison, E.; Niloff, J.M.; Lazarus, H.","year":"1983","unstructured":"Bast RC, Klug TL, John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl JMed 1983;309:883-7.","journal-title":"N Engl JMed"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jcp.43.10.833","article-title":"Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours","volume":"43","author":"van Dam PA; JV, Watson; DG, Lowe; H, Cox; M, Curling; JH, Shepherd","year":"1990","unstructured":"van Dam PA, Watson JV, Lowe DG, Cox H, Curling M, Shepherd JH. Tissue preparation for simultaneous flow cytometric quantitation of tumour associated antigens and DNA in solid tumours. J Clin Pathol 1990;43:833-9.","journal-title":"J Clin Pathol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines","volume":"73","author":"Ross, J.F.; Chaudhuri, P.K.; Ratnam, M.","year":"1994","unstructured":"Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994;73: 2432-43.","journal-title":"Cancer"},{"key":"ref_20","first-page":"6708","article-title":"Cellular localization of the folate receptor-potential role in drug toxicity and folate homeostasis","volume":"52","author":"Weitman, S.D.; Weinberg, A.G.; Coney, L.R.; Zurawski, V.R.; Jennings, D.S.; Kamen, B.A.","year":"1992","unstructured":"Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor-potential role in drug toxicity and folate homeostasis. Cancer Res 1992;52:6708-11.","journal-title":"Cancer Res"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0959-8049(94)90257-7","article-title":"Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOvl9","volume":"30","author":"Mantovani, L.T.; Miotti, S.; Menard, S.; Canevari, S.; Raspagliesi, F.; Bottini, C.","year":"1994","unstructured":"Mantovani LT, Miotti S, Menard S, Canevari S, Raspagliesi F, Bottini C, et al. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOvl9. EurJ Cancer 1994;30A:363-9.","journal-title":"EurJ Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ijc.2910400608","article-title":"Antibody-antigen complex formation following injection of I-131-labelled OC 125 monoclonal antibody F(ab')2 fragments into patients with ovarian carcinoma","volume":"40","author":"Haisma, H.J.; Knapp, R.C.; Battaille, A.; Stradtman, E.W.; Zurawski, V.R.","year":"1987","unstructured":"Haisma HJ, Knapp RC, Battaille A, Stradtman EW, Zurawski VR. Antibody-antigen complex formation following injection of I-131-labelled OC 125 monoclonal antibody F(ab')2 fragments into patients with ovarian carcinoma. Int J Cancer 1987;40:758-62.","journal-title":"Int J Cancer"},{"key":"ref_23","first-page":"1289","article-title":"Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies","volume":"10","author":"Boerman, O.C.; Massuger, L.F.A.G.; Makkink, W.K.; Thomas, C.M.G.; Kenemans, P.; Poels, L.G.","year":"1990","unstructured":"Boerman OC, Massuger LFAG, Makkink WK, Thomas CMG, Kenemans P, Poels LG. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies. Anticancer Res 1990;10: 1289-96.","journal-title":"Anticancer Res"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0028-2243(90)90201-B","article-title":"CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer","volume":"36","author":"Kenemans, P.","year":"1990","unstructured":"Kenemans P. CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancer. EurJ Obstet Gynecol Reprod Biol 1990;36:221-38.","journal-title":"EurJ Obstet Gynecol Reprod Biol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/bjc.1992.144","article-title":"Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC 125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer","volume":"65","author":"MolthoffCFM, Pinedo H.M.; HMM, Schluper; HW, Nijman; E, Boven","year":"1992","unstructured":"MolthoffCFM, Pinedo HM, Schluper HMM, Nijman HW, Boven E. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC 125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer. Br Jf Cancer 1992;65: 677-83.","journal-title":"Br Jf Cancer"},{"key":"ref_26","first-page":"281","article-title":"Multiple parameter analyses ofhuman ovarian cancer: morphology, immunohistochemistry, steroid hormone receptors and aromatase","volume":"8","author":"Kuhnel, R.; Rao, B.R.; Poels, L.G.; Delemarre, J.F.M.; Kenemans, P.; StolkJG","year":"1988","unstructured":"Kuhnel R, Rao BR, Poels LG, Delemarre JFM, Kenemans P, StolkJG. Multiple parameter analyses ofhuman ovarian cancer: morphology, immunohistochemistry, steroid hormone receptors and aromatase. Anticancer Res 1988;8: 281-6.","journal-title":"Anticancer Res"},{"key":"ref_27","first-page":"1177","article-title":"Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'","volume":"343","author":"Riethmuller, G.; Schneider-Gadicke, E.; Schlimok, G.; Schmiegel, W.; Raab, R.; Hofiken, K.","year":"1994","unstructured":"Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hofiken K, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;343: 1177-83.","journal-title":"C colorectal carcinoma. Lancet"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.48.7.631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:40:39Z","timestamp":1765600839000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.48.7.631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1995,7,1]]},"published-print":{"date-parts":[[1995,7]]}},"alternative-id":["10.1136\/jcp.48.7.631"],"URL":"https:\/\/doi.org\/10.1136\/jcp.48.7.631","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]}}}